Effect of occlusion on the percutaneous penetration of linoleic acid and glycerol

International Journal of Pharmaceutics

Volumn 249, Issue 1-2, 2002, Pages 157-164

  Taylor, Louise J ^a   Lee, Robert S ^a   Long, Mark ^a   Rawlings, Anthony V ^a   Tubek, Joseph ^a   Whitehead, Lynne ^a   Moss, Gary P ^a,b  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Glycerol; Linoleic acid; Occlusion; Percutaneous absorption; Porcine skin

Indexed keywords

ALCOHOL; CYCLOMETHICONE; DRUG VEHICLE; GLYCEROL; LINOLEIC ACID; UNCLASSIFIED DRUG; VOLATILE AGENT;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TISSUE LEVEL; EVAPORATION; MALE; NONHUMAN; OCCLUSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN; SKIN PENETRATION; SKIN TEMPERATURE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; INTRADERMAL DRUG ADMINISTRATION; PHYSIOLOGY; SKIN ABSORPTION; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; GLYCEROL; LINOLEIC ACID; MALE; SKIN ABSORPTION; SWINE;

EID: 0037027856     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00489-1     Document Type: Article

References (29)

1. Akhter S.A., Barry B.W. Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidine. J. Pharm. Pharmacol. 37:1985;27-37.
2. Barry B.W. Dermatological Formulations. 1983;Marcel Dekker, New York.
3. Barry B.W., Bennett S.L. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39:1987;535-546.
4. Behl C.R., Flynn G.L., Kurihara T., Harper N., Smith W., Higuchi W.M., Ho N.F., Pierson C.L. Hydration and percutaneous absorption I: Influence of hydration on alkanol permeation through hairless mouse skin. J. Invest. Dermatol. 75:1980;346-353.
5. Bucks B.A.W., Maibach H.I., Guy R.H. Occlusion does not uniformly enhance penetration in vivo. Bronaugh R.L., Maibach H.I., Percutaneous Absorption. Mechanisms, Methodology, Drug Delivery. second ed. 1989;77-93 Marcel Dekker, New York.
6. Cleek R.L., Bunge A.L. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm. Res. 10:1993;497-506.
7. Cronin M.T.D., Dearden J.C., Moss G.P., Murray-Dickson G. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur. J. Pharm. Sci. 7:1999;325-330.
8. Edwardson P.A.D., Walker M., Breheny C. Quantitive FT-IR determination of skin hydration following occlusion with hydrocolloid containing adhesive dressings. Int. J. Pharm. 91:1993;51-57.
9. Elias P.M., Brown B.E., Zibon V.A. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J. Invest. Dermatol. 74:1980;230-233.
10. Feldman R.J., Maibach H.I. Regional variation in percutaneous absorption of 14C-cortisol in man. J. Invest. Dermatol. 48:1967;181-183.
11. Fluhr J.W., Gloor M., Lehmann L., Lazzerini S., Distante F., Berardesca E. Glycerol accelerates recovery of barrier function in vivo. Acta Derm. Venereol. 79:1999;418-421.
12. Hansch C., Leo A., Hoekman D. Exploring QSAR: Hydrophobic, Electronic and Stearic Constants. 1995;American Chemical Society, Washington, DC.
13. Høelgaard A., Møllgaard B. Permeation of linoleic acid through skin in vitro. J. Pharm. Pharmacol. 34:1982;610-611.
14. Houtsmuller U.T.M., Beek A. Effects of topical application of fatty acids. Prog. Lipid Res. 20:1981;219-224.
15. Hunt C.E., Engel R.R., Modler S., Hamilton W., Bissen S., Holman R.T. Essential fatty acid deficiency in neonates: Inability to reverse deficiency by topical applications of EFA-rich oil. J. Pediatr. 92:1978;603-607.
16. Idson B. In vivo measurement of trans-epidermal water loss. J. Soc. Cosm. Chem. 29:1978;573-580.
17. Kondo S., Yamanaka C., Sugimoto I. Enhancement of transdermal delivery by superflous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. J. Pharmacobio-Dyn. 10:1987;743-749.
18. McCafferty D.F., Woolfson A.D., Boston V. In vivo assessment of percutaneous local anaesthetic preparations. Br. J. Anaesth. 62:1989;17-21.
19. Press M., Hartop P.J., Prottey U. Correction of essential fatty acid deficiency in man by the cutaneous application of sunflower oil. Lancet. 1:1974;597-598.
20. Scholtz J.R., Calif P. Topical therapy of psoriasis with flucinolone acetonide. Arch. Dermatol. 84:1961;1029-1030.
21. Shelmire J.B. Factors determining the skin-drug-vehicle relationship. Arch. Dermatol. 82:1960;24-31.
22. Stinchomb A.L., Pirot F., Touraille G.D., Bunge A.L., Guy R.H. Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm. Res. 16:1999;1288-1293.
23. Sulzberger M.B., Witten V.H. Thin pliable plastic films in topical dermatological therapy. Arch. Dermatol. 84:1961;1027-1029.
24. Treffel P., Muret P., Muretdaniello P., Coumesmarquet S., Agache P. Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties. Skin Pharmacol. 5:1992;108-113.
25. Turraha L., Ali-Fossi N. Influence of propylene glycol on the release of hydrocortisone and its acetate ester from Carbopol® hydrogels. Acta Pharm. Fennica. 96:1987;15-21.
26. Vickers C.F.H. Existence of reservoir in the stratum corneum: experimental proof. Arch. Dermatol. 88:1963;72-75.
27. Woolfson A.D., McCafferty D.F., Boston V. Clinical experiences with a novel percutaneous amethocaine preparation: prevention of pain due to venepuncture in children. Br. J. Clin. Pharm. 30:1990;273-279.
28. Woolfson A.D., McCafferty D.F., McGowan K.E. Percutaneous penetration characteristics of amethocaine through porcine and human skin. Int. J. Pharm. 78:1992;209-216.
29. Zhai H.B., Maibach H.I. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 14:2001;1-10.